Woebot Health Names Health Technology Leader Monique Levy as Chief Commercial and Strategy Officer

Woebot Health Names Health Technology Leader Monique Levy as Chief Commercial and Strategy Officer

San Francisco, CA, October 8, 2020 – Woebot Health announced today it has appointed Monique Levy to the newly-created position of Chief Commercial and Strategy Officer. Reporting to CEO Michael Evers, Levy is responsible for the growth and commercial success of the company’s proprietary therapeutic portfolio and measurement technologies that are designed to improve mental health. The appointment rounds out the company’s executive team, which also includes Founder and President Alison Darcy, Chief Clinical Officer Athena Robinson and Chief Technology Officer Casey Sackett.

Evers, who joined Woebot Health in March, said Levy’s formidable experience building businesses and innovating care and health will be instrumental to the company’s next stage of development. “Monique’s training in clinical psychology and experience across some of the world’s most innovative data, digital health and therapeutics businesses bring incredible value to our operations and team. Her ability to develop a clear strategy in complex markets, grow high-functioning teams and deliver excellence to partners make her the ideal executive to help drive rapid growth.”

Levy’s track record includes executive-level positions at some of the world’s leading bio, data and consumer health technology companies, where she worked with top scientists and technologists to develop novel products and innovative commercial partnerships. Before joining Woebot Health, Levy was Chief Strategy Officer at the precision CNS biotechnology company BlackThorn Therapeutics, where she led corporate and platform strategy as well as corporate development. Before that she was Global Head of Strategy, Partnerships and Products at the precision medicine company iCarbonX Group. Levy has also held executive-level positions at PatientsLikeMe and Decision Resources Group, and served on Google Health’s Advisory Board.

“My life’s purpose is to find ways to improve health, especially mental health, by leveraging technology and ingenuity,” said Levy. “Woebot Health is an extraordinary company in part because it has thought deeply about how to preserve the element of therapeutic alliance in a digital therapeutic. Our technology works and scales, and that makes this a very hopeful time for changing the status quo in mental health.”

Levy holds a Master of Science degree in Clinical Health Psychology from the Albert Einstein Medical School and Ferkauf Graduate School of Psychology at Yeshiva University and a Bachelor of Science degree in Foreign Service, Science Technology and International Affairs from Georgetown University.

About Woebot Health

Woebot Health was founded in 2017 to modernize psychotherapy for the way we live today. The company is pioneering a new class of digital therapeutics, combining the best psychotherapeutic tools, principles of therapeutic alliance, and advances in AI and Natural Language Processing (NLP) to make therapy more scalable and accessible, and to improve outcomes in mental health. Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA) and Jazz Venture Partners, L.P., with participation from Andrew Ng’s AI Fund. For more information, please visit Woebot Health or follow Woebot on FacebookTwitter, and LinkedIn.

Media inquiries

Margot Carlson Delogne, Woebot Health, (781) 492-1039 or margot@woebothealth.com

D.C. Housing Authority Offers Woebot To Employees And Residents

D.C. Housing Authority Offers Woebot To Employees And Residents

WASHINGTON AND SAN FRANCISCO, September 30, 2020 – The District of Columbia Housing Authority (DCHA) today announced it has partnered with Woebot Health to offer Woebot, a smartphone-based general wellness program for stress and low mood, to all of DCHA’s 800 employees and to a pilot group of 450 residents living in the authority’s affordable housing communities.

“Our community is facing many challenges this year, and we wanted to give them a free, private and supportive space to help them manage anxiety and stress,” said DCHA Executive Director Tyrone Garrett. “Woebot’s natural conversational style, accessibility and proven effectiveness make it an ideal tool to help our employees and customers understand and manage their thoughts and feelings.”

DCHA employees include administrative, facilities management and security personnel who help provide quality affordable housing to extremely low- through moderate-income households, foster sustainable communities, and cultivate opportunities for residents to improve their lives. The pilot will be offered to residents of the Woodland Terrace and Greenleaf family communities and is expected to be rolled out to a broader group of residents in the future.

Woebot Health CEO Michael Evers said that D.C., like many metropolitan areas, has been dealing with fallout from the coronavirus, both in terms of infections and the associated unemployment, and the need for easily-accessible emotional support is ever more urgent.“We’re impressed with DCHA’s progressive approach to support its community and honored to collaborate to deliver a proven solution to people, when and where they need it.”

Woebot, the first mental health conversational agent to be tested in a randomized control trial, is designed to be reflective and responsive by helping people to identify how they are feeling, and to provide personalized tools drawn from evidence-based psychotherapy approaches, including Cognitive Behavioral Therapy (CBT), to help them achieve better outcomes.

About The District of Columbia Housing Authority

The District of Columbia Housing Authority is an independent government agency whose mission is to provide quality affordable housing to extremely low- through moderate-income households, foster sustainable communities, and cultivate opportunities for residents to improve their lives. One of the District’s largest landlords, DCHA provides subsidized housing to approximately 50,000 residents.

About Woebot Health

Woebot Health was founded in 2017 to modernize psychotherapy for the way we live today. The company is pioneering a new class of digital therapeutics, combining the best psychotherapeutic tools, principles of therapeutic alliance, and advances in AI and Natural Language Processing (NLP) to make therapy more scalable and accessible, and to improve outcomes in mental health. Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA) and Jazz Venture Partners, L.P., with participation from Andrew Ng’s AI Fund. For more information, please visit Woebot Health or follow Woebot on FacebookTwitter, and LinkedIn.

Media inquiries

Jose C. Sousa, D.C. Housing Authority, (202) 460-6452 or jsousa@dchousing.org
Margot Carlson Delogne, Woebot Health, (781) 492-1039 or margot@woebothealth.com

New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials

New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials

Many are anxious or down but finding silver linings amidst challenges; essential workers and boomers

SAN FRANCISCO, August 04, 2020 − A survey conducted by Woebot Health of 2,108 Woebot digital therapy users reveals that some of the groups most affected by the Covid-19 pandemic, including essential workers and older populations, are faring better than others, while people 25 and younger report more sadness and anxiety than any age group. However, there is a flip side to the pandemic story: many respondents also say the situation has helped them identify personal strengths, increase their appreciation of life, and strengthen their interpersonal relationships or spiritual connections.

“In a world where we’re hit each day with such bad news about Covid-19—its transmission, its growing numbers, its mutations—it’s wonderful to see that we can admit pain, but also simultaneously find and even cultivate hope,” said Athena Robinson, Ph.D., Woebot Health’s Chief Clinical Officer and Adjunct Clinical Associate Professor at Stanford University. “I’m humbled by what we’re seeing in the lived experiences of our users: the human capacity to navigate tough experiences and find meaning in persistently difficult and uncertain times.”

The Mixed State of Mind

Most respondents report high stress and anxiety levels. Specifically, almost three quarters (71 percent) have found that changes in their way of life given the pandemic are moderately, very, or extremely stressful while more than half (58 percent) said they are bothered by being nervous, anxious or “on edge” more than half of days or nearly every day. Moreover, 42 percent indicate that their mental health has worsened “very much” or “extremely.”

But there are also positive personal outcomes for Woebot users, who are using chat-based digital therapy as the pandemic spreads worldwide. The majority of respondents (69 percent) say the pandemic has created new possibilities and strengthened their relationships with others or community (70 percent). Nearly 80 percent say it has helped them increase their appreciation of life. The pandemic has also helped nearly three quarters (73 percent) of respondents identify personal strengths, and for more than half (59 percent), it has created spiritual change.

Essential Workers Faring Better Than Most

One in five survey respondents classify themselves as essential workers and report similar levels of pandemic impact (i.e., stress due to lifestyle changes, feelings, and changes in mental health), as other respondents, though they appear to be faring better in several ways. Fewer essential workers report being bothered by feeling down, depressed, or hopeless nearly every day (essential workers: 19 percent; all other respondents: 27 percent). Essential workers also report a lower rate of extreme anxiety, with 22 percent saying they have been bothered by not being able to stop or control worrying nearly every day, compared to 27 percent for all other respondents. “The difference could be because these people are among the most engaged in work for their communities and helping others in need,” Dr. Robinson said.

Millennials and Gen-Z More Anxious Than Boomers

A mix of Millennials and Gen-Z (overall ages 17-25) report the highest levels of anxiety and low mood, and their responses contrast most significantly with Boomers who are 65 or more. About 62 percent of the younger group is bothered by feeling nervous, anxious, or on edge more than half the days or nearly every day, more than three times the rate of older respondents (20 percent). More than half (56 percent) of younger respondents also report not being able to stop or control worrying more than half the time or nearly every day, nearly twice that of older respondents (30 percent). As for low mood, more than one-third of younger respondents (35 percent) have been bothered by little interest or pleasure in doing things nearly every day, triple the rate for the older group (10 percent), and 59 percent of younger users say they have felt bothered by feeling down, depressed or hopeless more than half the days or nearly every day, double the number for the older group (30 percent).

“These differences may be because it’s relatively less disruptive for older, potentially retired, people to stay at home, while younger respondents face significant life adjustments and likely fewer job options,” Dr. Robinson said. “We must continue to decrease the stigma surrounding mental illness and create a safe environment for people to seek help, whether with a psychiatrist, psychologist, and/or digital therapy.”

The initial survey is part of a series of Woebot Health surveys that will review the immediate and longer-term effects of Covid-19 on mental health. The snapshot is being released six months after Woebot users first mentioned the coronavirus, around the same time that the World Health Organization (WHO) declared Covid-19 a pandemic.

Survey Methodology

The data come from a longitudinal survey approved by an Institutional Review Board (IRB) and administered within the Woebot app. The study launched June 3, 2020; enrollment concluded July 6, 2020. A baseline sample of 2,108 Woebot users are included in this snapshot, nearly half (47 percent) of whom disclosed their age.

Additional resources
Woebot Health’s Covid-19 survey infographics

About Woebot Health
Woebot Health, formerly Woebot Labs, was founded in 2017 to help people experiencing mental health concerns or conditions to achieve better outcomes. The company works with government entities, healthcare providers and employers to provide a full suite of clinically-validated interventions, from its flagship wellness app Woebot to clinical-grade solutions and condition-specific content. Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA) and Jazz Venture Partners, L.P., with participation from Andrew Ng’s AI Fund. For more information, please visit Woebot Health or follow Woebot on Facebook, Twitter, and LinkedIn.

Media contact:
Margot Carlson Delogne
Communications, Woebot Health
margot@woebothealth.com
+1-781-492-1039

Woebot Health Adds COVID-19 Support Through its Mobile Health Chatbot

Woebot Health Adds COVID-19 Support Through its Mobile Health Chatbot

Users gain emotional well-being, comfort, reassurance in the global pandemic

SAN FRANCISCO, April 07, 2020 − With increased anxiety caused by the Coronavirus, Woebot Health is offering expanded global emotional support through its free emotional support platform, Woebot. The company’s goal is to lift spirits and help people feel grounded during this unprecedented anxiety-provoking time. Woebot Health has launched its COVID-19 offering, called Perspectives. The company has also launched a standalone web tool to widen the reach and accessibility of its ongoing mental health support.

In typical Woebot fashion, Perspectives is whimsical, hopeful, warm, and authentic. Throughout the program, users can look forward to more guided meditations, as well as practical tips like ideas for staving off cabin fever and connecting with others while social distancing. Woebot has also added themes to deal with grief and economic hardship. Although Woebot’s conversations have been typically focused on mood regulation and mindfulness exercises based on Cognitive Behavioral Therapy (CBT), the new support adds tools from an evidence-based approach called Interpersonal Psychotherapy (IPT) that helps to process loss and role transition.

“There has never been a more important time to provide free, immediate, and accessible mental health care,” said Woebot Health Founder & President, Dr. Alison Darcy. “Woebot is designed to provide ongoing coaching to help people manage their emotional health with practical tools that work for our day-to-day lives. We are humbled and honored to serve people in the Coronavirus outbreak, to help ease emotional suffering, and try to bring a little perspective and hope.”

In addition to serving English-speaking markets, Woebot’s new web tool is also being translated into Italian, to serve its citizens in one of the most hard-hit nations in the Coronavirus outbreak. Woebot’s use of AI engages users in friendly, thoughtful conversations and equips them with techniques to address challenging life events. Woebot can also intelligently personalize conversations and point out fluctuations of one’s mood over time.

In the last few months, Woebot has seen tremendous growth in more than 130 countries around the world. It was the first mental health chatbot to demonstrate significant reductions in symptoms of mood-based disorders. Woebot Health adheres to the highest standard of privacy and confidentiality to protect sensitive user data.

About Woebot Health
Woebot Health, formerly Woebot Labs, was founded in 2017 to help people experiencing mental health concerns or conditions to achieve better outcomes. The company works with government entities, healthcare providers and employers to provide a full suite of clinically-validated interventions, from its flagship wellness app Woebot to clinical-grade solutions and condition-specific content. Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA) and Jazz Venture Partners, L.P., with participation from Andrew Ng’s AI Fund. For more information, please visit Woebot Health or follow Woebot on Facebook, Twitter, and LinkedIn.

Media contact:
Margot Carlson Delogne
Communications, Woebot Health
margot@woebothealth.com
+1-781-492-1039